从液体SNEDDS到固体SNEDDS:对其发展和制药应用的全面审查
Sandrine Tanga1, Poornima Ramburrun2, Marique Aucamp3
1School of Pharmacy, Faculty of Natural Sciences, University of the Western Cape, Bellville, 7535, South Africa.
The AAPS journal
|October 31, 2025
概括
本综述比较了液体和固体自纳米乳化药物递送系统 (SNEDDS),以提高药物的溶解性和吸收性. 它指导研究人员根据生产,性能和人工智能驱动的设计潜力选择最佳的SNEDDS配方.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 纳米技术 纳米技术
背景情况:
- 自行纳米乳化药物递送系统 (SNEDDS) 对于提高疏水药物的可溶性和生物利用性至关重要.
- 液体和固体SNEDDS配方均可提供增强的药物吸收能力,但选择取决于诸如可移植性,患者遵守性和制备容易等因素.
研究的目的:
- 提供液体和固体SNEDDS配方的全面分析.
- 通过检查生产和性能因素,指导研究人员选择最佳的SNEDDS剂型.
- 探索人工智能在SNEDDS配方设计中的作用.
主要方法:
- 对SNEDDS配方的文献综述,重点关注辅助剂的特性和稳定性.
- 分析液体到固体的制备方法,包括相关的挑战.
- 液体和固体SNEDDS体内和体外性能的比较.
主要成果:
- 液体和固体SNEDDS都提高了药物的生物可用性.
- 配方选择的关键考虑因素包括可移植性,患者遵守性,给药途径和易于制备.
- 辅助剂的选择,稳定性和制造工艺显著影响SNEDDS的性能.
结论:
- 液体和固体SNEDDS之间的选择取决于具体的应用要求和所需的药物输送特性.
- 对人工智能应用的进一步研究可以优化SNEDDS配方开发.
- SNEDDS代表了先进药物输送的有希望的平台,特别是对于难以溶解的化合物.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
142
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
142
Bioavailability Enhancement: Drug Solubility Enhancement
210
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
210
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Bioavailability Enhancement: Drug Permeability Enhancement
182
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
182


